» Authors » Rick Ikesaka

Rick Ikesaka

Explore the profile of Rick Ikesaka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 37
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schulman S, Bhagirath V, Chan N, Germini F, Ikesaka R, Iorio A, et al.
J Thromb Haemost . 2024 Jul; 22(10):2761-2766. PMID: 39002730
Background: It is uncertain whether prothrombin complex concentrate (PCC) improves hemostasis in patients on treatment with oral factor Xa-inhibitors (XaI) who require emergency surgery. Objectives: To evaluate whether, in patients...
2.
Germini F, Al-Haimus F, Hu Y, Mondoux S, Ibrahim Q, Chan N, et al.
Ann Emerg Med . 2024 Apr; 84(5):508-517. PMID: 38661619
Study Objective: Computed tomography pulmonary angiogram (CTPA) is overused during pulmonary embolism (PE) testing in the emergency department (ED), whereas prediction rules and D-dimer are underused. We report the adherence,...
3.
Al-Tourah L, Mithoowani S, Lim W, Ikesaka R
J Thromb Thrombolysis . 2024 Mar; 57(4):630-637. PMID: 38429468
Background: Direct oral anticoagulants (DOACs) are the mainstay of treatment for venous thromboembolism (VTE) and non-valvular atrial fibrillation (AF), with or without an underlying cancer. Patients with cancer have a...
4.
de Wit K, Ikesaka R, Chan N, Germini F
Ann Emerg Med . 2023 Mar; 81(4):517-518. PMID: 36948692
No abstract available.
5.
de Wit K, Al-Haimus F, Hu Y, Ikesaka R, Chan N, Ibrahim Q, et al.
Ann Emerg Med . 2022 Nov; 81(5):558-565. PMID: 36371248
Study Objective: We prospectively assessed the diagnostic accuracy of YEARS and a modified age-adjusted clinical decision rule ("Adjust-Unlikely") for pulmonary embolism (PE) testing in the emergency department. Methods: This study...
6.
Ikesaka R, Kaur B, Crowther M, Rajasekhar A
J Thromb Thrombolysis . 2022 Aug; 54(3):502-523. PMID: 35960423
Prophylactic placement of inferior vena cava (IVC) filters prior to performing bariatric surgery is an intervention of unclear safety and efficacy with disagreement between current practice guidelines. To better characterize...
7.
Schulman S, Carlson V, Serrano P, Sne N, Kahnamoui K, Mithoowani S, et al.
J Surg Oncol . 2022 Apr; 126(2):386-393. PMID: 35362102
Background: Due to lack of data, direct oral anticoagulants are not considered by guidelines for venous thromboembolism (VTE) prophylaxis after cancer surgery. Adherence to low-molecular-weight heparin injections in this setting...
8.
Li A, Brandt W, Brown C, Wang T, Ikesaka R, Delluc A, et al.
Thromb Res . 2021 Oct; 208:58-65. PMID: 34715510
Background: Venous thromboembolism (VTE) is a leading cause of mortality in patients with cancer and is associated with significant morbidity and healthcare expenditure. The risk of VTE is increased following...
9.
Ikesaka R, Siegal D, Mallick R, Wang T, Witham D, Webb C, et al.
Res Pract Thromb Haemost . 2021 May; 5(4):e12517. PMID: 34027291
Background: Central venous catheter (CVC) insertion is an important risk factor for venous thromboembolism (VTE) among patients with cancer. Routine use of primary thromboprophylaxis in this patient population is not...
10.
Mirza R, Nieuwlaat R, Lopez-Nunez J, Barba R, Agarwal A, Font C, et al.
Blood Adv . 2020 Jun; 4(11):2460-2467. PMID: 32497167
Because of the absence of comparative evidence, current guidelines and product monographs diverge in the dosing of low-molecular-weight heparin (LMWH) for obese patients with venous thromboembolism (VTE). We used the...